Pituitary adenomas (PAs) are adenohypophysial neoplasms, representing~ 10–15% of all
intracranial tumors, which are found to occur in almost 20% of the general population (1, 2) …

High-risk pituitary adenomas are aggressive. They show clinical and imaging features
similar to those of carcinomas, including infiltration of the surrounding brain structures, but …

Pituitary adenomas (PAs) are neoplasms derived from the endocrine cells of the anterior
pituitary gland. Most frequently, they are benign tumors, but may sometimes display an …

In this special issue, eminent international experts and collaborators from several continents
appraise the present landscape regarding aggressive pituitary tumors, from epidemiology …

Chemokines are chemotactic regulators of immune surveillance in physiological and
pathological conditions such as inflammation, infection, and cancer. Several chemokines …

Pituitary tumors are common and exhibit a wide spectrum of hormonal, proliferative and
invasive behaviors. Traditional classifications consider them malignant only when they …

Pituitary adenomas are common intracranial tumors that are mainly considered as benign.
Rarely, these tumors can exhibit an aggressive behavior, characterized by gross invasion of …

Pituitary adenomas are a category of neoplasms with a high degree of heterogeneity that
occur in the central regulatory organ pituitary, which plays important roles in the …

Symptomatic pituitary tumors represent 5% to 10% of all brain tumors and are mostly benign.
Up to 30% of macroadenomas grow invasively (mostly defined clinically by imaging), 15 …

The fourth edition of the World Health Organization classification of endocrine tumors has
been recently published. There are two critical changes to the classification for pituitary …